This pilot clinical trial was a 15-week, double-blind, controlled, three-way crossover study evaluating cognitive effects of ceranapril in subjects with dementia of the Alzheimer type (age range 50-75 years). Computerized (CNTB) and noncomputerized cognitive test batteries revealed no significant results (p > 0.05). On further analysis of the data, however, a study of longer duration and/or higher dosages may be warranted.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/00002093-199307020-00006 | DOI Listing |
Publication Analysis
Top Keywords
pilot clinical
8
clinical trial
8
trial angiotensin-converting
4
angiotensin-converting enzyme
4
enzyme inhibitor
4
inhibitor ceranapril
4
ceranapril alzheimer
4
alzheimer disease
4
disease pilot
4
trial 15-week
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!